Pavimol Angsantikul

Pavimol Angsantikul currently serves as a Pharmaceutical Development Scientist and Head of Laboratory at the Population Council. In this role, she leads the development of novel drug delivery systems and formulation technologies for women’s sexual and reproductive health. Her work primarily focuses on advancing non-hormonal contraception and STI prevention products, including lipid-based formulations and freeze-dried technologies. Angsantikul collaborates closely with cross-functional teams on preclinical formulation development, process optimization, and scale-up. Additionally, she oversees the integration of cutting-edge technologies into product design, ensuring robust product stability, efficacy, and regulatory compliance. Her current projects include developing fast-disintegrating inserts (FDI) and novel vaginal delivery platforms to address key, unmet needs in reproductive health. She is also focused on enhancing user experience through optimized drug delivery.

Angsantikul has extensive expertise in the development of nanoparticle-based drug delivery systems, particularly for biologics, vaccines, and lyophilized formulations. Her innovative work spans multiple areas, including the development of cell membrane-coated nanoparticles and the optimization of protein formulations for stability and efficacy. Angsantikul has contributed significantly to pharmaceutical sciences, with over 40 publications in high-impact peer-reviewed journals. Angsantikul is also the inventor of a drug delivery technology, currently being filed for patent, based on her postdoctoral research on oral delivery of biologics.

Angsantikul holds a BEng in Nano Engineering from Chulalongkorn University, Thailand, where she graduated first in her class, and a PhD in Nano Engineering from the University of California, San Diego.